Company Overview and News

 
ICE exchange to launch three-month Sonia futures contract in June

2018-04-18 reuters
LONDON (Reuters) - The Intercontinental Exchange (ICE.N) said on Wednesday it will launch a three-month futures contract based on “Sonia”, the Bank of England’s interest rate benchmark which aims to replace Libor.
Upvote Downvote

 
Global Real Estate Shows Its Strength

2018-04-17 seekingalpha
As the global economy exhibited solid growth and central banks rolled back their post-crisis stimulus in a steady fashion, inflation worries have now come to the forefront, especially in interest-rate sensitive sectors like real estate.
Upvote Downvote

 
Competition Is The Mother Of Innovation

2018-04-15 seekingalpha
Critics from many corners of the political and financial spectrum are calling for Google, Facebook and Amazon to be broken up.1 A key aspect of the argument is that these tech giants have become powerful businesses that stifle competition and in turn hurt innovation. A similar assertion has been whispered around the market data industry by some regarding the biggest index providers. However, aside from each industry being led currently by a group of leading firms amongst a wealth of other providers, the comparison falls flat under closer review.
Upvote Downvote

 
LSE Hires Goldman's Schwimmer as CEO, Ending Long Search - Bloomberg

2018-04-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Premarket: 6 things to know before the bell

2018-04-13 money.cnn
In a meeting Thursday, Trump asked his team to investigate "whether or not a better deal could be negotiated," the White House said.
Upvote Downvote

 
London Stock Exchange Group appoints Goldman's Schwimmer as CEO

2018-04-13 channelnewsasia
REUTERS: London Stock Exchange Group Plc said it appointed Goldman Sachs' David Schwimmer as chief executive officer effective Aug. 1.
Upvote Downvote

 
London Stock Exchange Group appoints Goldman's Schwimmer as CEO

2018-04-13 reuters
(Reuters) - London Stock Exchange Group Plc (LSE.L) said it appointed Goldman Sachs’ (GS.N) David Schwimmer as chief executive officer effective Aug. 1.
Upvote Downvote

 
London Stock Exchange Group appoints Goldman's Schwimmer as CEO

2018-04-13 reuters
April 13 (Reuters) - London Stock Exchange Group Plc said it appointed Goldman Sachs’ David Schwimmer as chief executive officer effective Aug. 1.
Upvote Downvote

 
Ex-Goldman Trader Teams Up With Millennials to Make AI Dark Pool - Bloomberg

2018-04-11 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Index IDEA: Multi-Factor Indexes Mine Long-Term Benefits Of Quality And Value

2018-04-10 seekingalpha
Global index provider FTSE Russell recently compared historical and current index performance and characteristics for the Russell 1000 2Qual/Val 5% Capped Index relative to the US large cap Russell 1000 Index. Findings help illustrate how indexes that blend market factors in an intelligent and systematic way may be an effective tool for long-term investors:
Upvote Downvote

 
Emerging Markets: Keep An Eye On Reform

2018-04-03 seekingalpha
The global economic expansion, along with reasonable valuations, supports our current preference for overweighting emerging market (EM) equities.
Upvote Downvote

 
Death of Global Exchange M&A? Not If CME's Duffy Can Help It - Bloomberg

2018-03-29 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
CME to buy Spencer’s NEX for £3.9b to create trading venue behemoth

2018-03-29 themalaymailonline
People enter the CME Group offices in New York October 18, 2017. — Reuters picNEW YORK, March 29 — CME Group Inc agreed to buy Michael Spencer’s NEX Group Plc in a transatlantic deal that creates a trading venues giant spanning futures to Treasuries and foreign exchange.
Upvote Downvote

 
Index IDEA: Large-Cap U.S. Sectors Have More Ups And Downs In 2018

2018-03-25 seekingalpha
After a 21.7% return for the US large cap Russell 1000 Index in 2017 in which all but one sector had positive returns, 2018 has been more of a mixed bag with sector returns. The Index has a return of -0.7% in 2018 (as of March 22) amid heightened market volatility, rising interest rates and growing global trade concerns, with more mixed returns across sectors.
Upvote Downvote

 
Regret Risk And Ways To Manage It

2018-03-21 seekingalpha
“Non, je ne regrette rien!” (No, I regret nothing!), the great French chanteuse, Edith Piaf, famously sang. It was the defiant declaration of a woman who had lived through many triumphs and tragedies but never second-guessed herself. She probably didn’t do much investing, however, because investors often second-guess their choices regarding the security or fund they could have invested in but didn’t before it soared in value, or the one they did invest in that dropped like a stone.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...